Solution structures and integrin binding activities of an RGD peptide with two isomers
about
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculaturePeptides as targeting probes against tumor vasculature for diagnosis and drug deliverySelection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3Specialization of tumour vasculature.Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptidesTherapeutic cancer targeting peptides.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesMolecular imaging of angiogenesis with SPECT.Integrin-targeting block copolymer probes for two-photon fluorescence bioimaging.Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.Peptide targeting of adenoviral vectors to augment tumor gene transferSynthesis and cell adhesive properties of linear and cyclic RGD functionalized polynorbornene thin filmsSmall molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imagingTargeted nanoparticle-based drug delivery and diagnosis.RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy.Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands.Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.The disulfide bond of an RGD4C motif inserted within the Hi loop of the adenovirus type 5 fiber protein is critical for retargeting to αv -integrins.Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IXA Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.A complex extracellular sphingomyelinase of Pseudomonas aeruginosa inhibits angiogenesis by selective cytotoxicity to endothelial cellsElectronic structure, dielectric response, and surface charge distribution of RGD (1FUV) peptide.Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif.Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli.Conformational flexibility and loss of structural rigidity for a model hexapeptide, GRGDTP: 1H-NMR and molecular dynamics studies.Combined 1H-NMR and molecular dynamics studies on conformational behavior of a model heptapeptide, GRGDSPC.Eco-friendly combination of the immobilized PGA enzyme and the S-Phacm protecting group for the synthesis of Cys-containing peptides.A third-generation density-functional-theory-based method for calculating canonical molecular orbitals of large molecules.Highly sensitive SERS analysis of the cyclic Arg-Gly-Asp peptide ligands of cells using nanogap antennas.Secondary Structure of Decorin-Derived Peptides in Solution
P2860
Q24799893-8FB80F2D-E687-4476-82E3-9DACE2DEE941Q27024850-D5A47238-374E-491D-BC70-855DF8FF67E5Q27636935-B89A1170-3B41-4C82-A822-ADB2AD6B5E21Q30896811-21777D24-A481-4746-B003-1DDCA89CB5E9Q30990845-E3444F12-8DF6-46A2-81BA-91E3BF3F9955Q33184888-B3894346-97D0-47B1-83F8-E1623D12E5A1Q33664307-C181B2C7-2C8F-4BBF-BB8D-E76AAAAFA06CQ34040149-CB6E46EE-B6AB-4A4C-9D36-07422538E629Q34579412-79067F68-941D-4673-A0A9-6C3DBDB216A6Q34669572-17585A0C-B3E3-437B-B664-B5D453635ABFQ35997103-6BC0C4B4-39F7-4CF7-AA61-E4B1C22A0C5EQ36049440-0AE3C0A8-C0E2-4766-82B8-83B8B6744ECDQ36234337-15312A0F-56A2-4AED-A3E8-CF79AA70F901Q36610302-10BEF737-1FC1-4D3E-AF95-AAAF43D8C711Q36799773-25F45A45-6A28-434B-B8BD-C55168D8289CQ37112974-D16E1C21-D54F-4FEF-AB3E-CAA349494AB7Q37336836-F3DC9972-5ABD-4948-9ADA-7A4F542E071CQ37344830-8045732F-2AD0-448A-BC8A-50509EE21564Q37635384-63CA574B-B7CE-48D5-9258-3A059D6A507AQ39241446-ABF04647-97CB-48CF-9F08-B27D580AB8FAQ39410097-F543AE9E-57DB-4884-84D6-BBF099881513Q40573323-E74FA719-B56C-43CE-B436-7135557A0697Q40579221-B7D2D214-6BDA-4BDB-8738-9D27E7A4AB93Q41195862-E2133B24-35F2-4BA7-A86F-658307E5E830Q41439632-F5531C5C-F695-4582-B206-46B10F8D6634Q41972670-8D662FBD-BC7D-420C-88C4-9C1B99028965Q42115409-FDFDAC24-1BF5-457A-8C68-DD227D17D360Q44174346-7B9330ED-1468-4C85-9A27-437F862F45ECQ45330895-BABD0B70-AD08-4319-B341-13DAFFA65761Q46719929-50AEB0D2-C6B3-4ADF-963F-7984E69A391BQ46731221-BD915060-F4A0-4499-800D-EF12E7CD192EQ50488990-C274CB81-851E-4245-9BD7-D64F2A97B9D8Q50857657-CE9720EB-CD1F-4F91-8F86-E419F1B16FD7Q51348989-D73B4BCF-76EC-40BA-A406-26BB2275EA63Q59294039-58485AC9-3FD2-4432-99B2-59C0C42BC3C8
P2860
Solution structures and integrin binding activities of an RGD peptide with two isomers
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Solution structures and integrin binding activities of an RGD peptide with two isomers
@ast
Solution structures and integrin binding activities of an RGD peptide with two isomers
@en
Solution structures and integrin binding activities of an RGD peptide with two isomers
@nl
type
label
Solution structures and integrin binding activities of an RGD peptide with two isomers
@ast
Solution structures and integrin binding activities of an RGD peptide with two isomers
@en
Solution structures and integrin binding activities of an RGD peptide with two isomers
@nl
prefLabel
Solution structures and integrin binding activities of an RGD peptide with two isomers
@ast
Solution structures and integrin binding activities of an RGD peptide with two isomers
@en
Solution structures and integrin binding activities of an RGD peptide with two isomers
@nl
P2093
P3181
P356
P1433
P1476
Solution structures and integrin binding activities of an RGD peptide with two isomers
@en
P2093
P304
P3181
P356
10.1021/BI002101F
P407
P577
2001-02-27T00:00:00Z